-+ 0.00%
-+ 0.00%
-+ 0.00%

BLACK DIAMOND THERAPEUTICS ANNOUNCES ORAL PRESENTATION OF SILEVERTINIB PHASE 2 DATA IN FRONTLINE EGFRM NSCLC PATIENTS AT THE 2026 ASCO ANNUAL MEETING

Reuters·04/21/2026 14:40:00

Please log in to view news